Results from a 380-patient investigational device exemption study demonstrate that SECURE-C is statistically superior to anterior cervical discectomy and fusion in terms of overall success, subsequent surgery at the index level, device-related adverse events and patient satisfaction at 24 months.
More Articles on Orthopedic Devices:
37 Orthopedic & Spine Devices Receives FDA 510(k) Clearance in September
Study: Generic Implants Save Hospital Over $34,600 Annually
Lakewood Ranch Medical Center in Florida Adopts MAKOplasty
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
